These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24128937)

  • 1. Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer.
    Ménard V; Lévesque E; Chen S; Eap O; Joy MS; Ekström L; Rane A; Guillemette C
    Pharmacogenet Genomics; 2013 Dec; 23(12):684-96. PubMed ID: 24128937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants.
    Ménard V; Eap O; Roberge J; Harvey M; Lévesque E; Guillemette C
    Pharmacogenet Genomics; 2011 Oct; 21(10):631-41. PubMed ID: 21881541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing.
    Ménard V; Collin P; Margaillan G; Guillemette C
    Drug Metab Dispos; 2013 Dec; 41(12):2197-205. PubMed ID: 24088326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.
    Margaillan G; Rouleau M; Fallon JK; Caron P; Villeneuve L; Turcotte V; Smith PC; Joy MS; Guillemette C
    Drug Metab Dispos; 2015 Apr; 43(4):611-9. PubMed ID: 25650382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin upregulates UDP glucuronosyltransferase 2B7 expression in liver cancer cells via the p53 pathway.
    Hu DG; Rogers A; Mackenzie PI
    Mol Pharmacol; 2014 Jun; 85(6):887-97. PubMed ID: 24682467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity.
    Girard H; Lévesque E; Bellemare J; Journault K; Caillier B; Guillemette C
    Pharmacogenet Genomics; 2007 Dec; 17(12):1077-89. PubMed ID: 18004212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation.
    Lévesque E; Ménard V; Laverdière I; Bellemare J; Barbier O; Girard H; Guillemette C
    Pharmacogenet Genomics; 2010 Mar; 20(3):195-210. PubMed ID: 20139797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.
    Ishii Y; Hansen AJ; Mackenzie PI
    Mol Pharmacol; 2000 May; 57(5):940-7. PubMed ID: 10779377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of human UDP-Glucuronosyltransferase 2B7 gene expression by cytotoxic anticancer drugs in liver cancer HepG2 cells.
    Hu DG; Mackenzie PI; Lu L; Meech R; McKinnon RA
    Drug Metab Dispos; 2015 May; 43(5):660-8. PubMed ID: 25713207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
    Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
    Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different fibroblast growth factor 1 (FGF-1) transcripts in neural tissues, glioblastomas and kidney carcinoma cell lines.
    Myers RL; Chedid M; Tronick SR; Chiu IM
    Oncogene; 1995 Aug; 11(4):785-9. PubMed ID: 7544453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The divergent 5' termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure.
    Elwood PC; Nachmanoff K; Saikawa Y; Page ST; Pacheco P; Roberts S; Chung KN
    Biochemistry; 1997 Feb; 36(6):1467-78. PubMed ID: 9063895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative tumor suppressor protein 4.1B is differentially expressed in kidney and brain via alternative promoters and 5' alternative splicing.
    Gascard P; Parra MK; Zhao Z; Calinisan VR; Nunomura W; Rivkees SA; Mohandas N; Conboy JG
    Biochim Biophys Acta; 2004 Oct; 1680(2):71-82. PubMed ID: 15488987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans.
    Bellemare J; Rouleau M; Harvey M; Popa I; Pelletier G; Têtu B; Guillemette C
    J Pathol; 2011 Feb; 223(3):425-35. PubMed ID: 21171088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.
    Innocenti F; Liu W; Fackenthal D; Ramírez J; Chen P; Ye X; Wu X; Zhang W; Mirkov S; Das S; Cook E; Ratain MJ
    Pharmacogenet Genomics; 2008 Aug; 18(8):683-97. PubMed ID: 18622261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
    Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
    Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative promoter usage of the membrane glycoprotein CD36.
    Andersen M; Lenhard B; Whatling C; Eriksson P; Odeberg J
    BMC Mol Biol; 2006 Mar; 7():8. PubMed ID: 16515687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of the human UGT2B7 gene.
    Carrier JS; Turgeon D; Journault K; Hum DW; Bélanger A
    Biochem Biophys Res Commun; 2000 Jun; 272(2):616-21. PubMed ID: 10833461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines.
    Bellemare J; Rouleau M; Harvey M; Têtu B; Guillemette C
    Pharmacogenomics J; 2010 Oct; 10(5):431-41. PubMed ID: 19997083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between promoter usage and alternative splicing of the glucocorticoid receptor gene.
    Russcher H; Dalm VA; de Jong FH; Brinkmann AO; Hofland LJ; Lamberts SW; Koper JW
    J Mol Endocrinol; 2007 Feb; 38(1-2):91-8. PubMed ID: 17242172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.